TrialInvestigational new drugs2015
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer.
Paul L Swiecicki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it